physio_marchetti
TL2 Physiotherapist · Bologna, IT
Physiotherapist. Resistance training during rapid weight loss, and realistic programming for people who are not athletes.
Joined 12 January 2025 · last posted 11d · groups: clinicians
79 posts, newest first. Showing up to 150.
-
What to bring: records that a clinician can actually use Replied, post #5 · Clinical › Prescriber conversations · 17 Jul 2026 · 0 likes Questions about dose: asking "how will we determine whether this dose is working for me" gets at the monitoring plan. Asking "can we start lower" or "can we escalate…
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #37 · Analytics › HPLC & UHPLC · 14 Jul 2026 · 30 likes Before anything else: what was the gradient, and at what wavelength? Area percent at different wavelengths is not the same number even on the same sample because…
-
Here for the analytics and not much else Replied, post #29 · Lounge › Introductions · 13 Jul 2026 · 0 likes No judgment: people come to this community from all backgrounds and with all motivations. Introductions are for getting to know each other, not for evaluation.
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #61 · Evidence › Journal club · 9 Jul 2026 · 29 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
-
How much context is too much context in a first post? Replied, post #3 · Start Here › How to Ask · 4 Jul 2026 · 6 likes Context that matters: compound, how long in, current dose, relevant history. Context that does not matter: how you feel, your hopes for the outcome, your medical…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #32 · Compounds › Retatrutide · 2 Jul 2026 · 1 like Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #45 · Analytics › Home & field testing · 2 Jul 2026 · 0 likes Colorimetric tests: colour intensity correlates with concentration, but the relationship is non-linear at extremes and the correlation depends on the exact conditions…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #92 · Analytics › HPLC & UHPLC · 1 Jul 2026 · 0 likes Before anything else: what was the gradient, and at what wavelength? Area percent at different wavelengths is not the same number even on the same sample because…
-
Does dual agonism explain the effect size, or is it dose? Replied, post #68 · Compounds › Tirzepatide · 29 Jun 2026 · 28 likes Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that means steady state is reached slightly faster and the post-dose…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #77 · Analytics › HPLC & UHPLC · 27 Jun 2026 · 5 likes post #76 is right about the mechanism and I think understates the practical bit. Gradient slope is the single biggest driver of apparent purity differences. A shallower…
-
Submitting a sample: the process end to end Replied, post #33 · Sourcing › Independent verification · 23 Jun 2026 · 0 likes Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks by mail; VendorInvestigate documentation review is…
-
A site rotation scheme that is easy enough to actually follow Replied, post #93 · Practice › Administration · 20 Jun 2026 · 6 likes Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after withdrawal is not a reason to assume you lost a significant dose.…
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #25 · Compounds › Secretagogues & GH axis · 17 Jun 2026 · 2 likes Evidence quality in the secretagogue literature is honestly weaker than in the incretin literature. Large randomised controlled trials are rare. Most evidence is…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #80 · Evidence › Journal club · 8 Jun 2026 · 5 likes Coming back to post #78, because the follow-up matters more than the original answer. TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #64 · Compounds › Tirzepatide · 18 May 2026 · 3 likes This follows post #61 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
When a dose reduction is the correct response to a side effect Replied, post #21 · Practice › Dosing & titration · 17 May 2026 · 0 likes This follows post #18 rather than contradicting it. Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence base from trials but…
-
How the vendor documentation pages are maintained, and by whom Started this topic · Sourcing › Vendor reports · 14 May 2026 · 25 likes How the vendor documentation pages are maintained, and by whom I have a specific reason for asking rather than idle curiosity, and the context is below. I would like to…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #139 · Pharmacology › Pharmacokinetics · 12 May 2026 · 1 like post #138 answers the question as asked. The question underneath it is different. Bioavailability: oral semaglutide has low bioavailability (roughly 1%) due to peptide…
-
Request declined, with reasoning — what changed since Replied, post #33 · Meta › Feature requests · 25 Apr 2026 · 12 likes Requests for platform and documentation features, with the reasoning that justifies them. If you think the site would be better with a feature, suggest it with enough…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #34 · Compounds › Repair & healing peptides · 8 Apr 2026 · 15 likes Stability of BPC-157 in solution: what has been measured in published work covers specific formulations under specific conditions. Extrapolating to a reconstituted…
-
Revisiting: Drawing up with one needle and injecting with another Replied, post #58 · Practice › Administration · 6 Apr 2026 · 0 likes I read post #56 twice before replying, because I had assumed the opposite. Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not…
-
Grapefruit: why this class is not the class that cares Replied, post #83 · Practice › Interactions · 26 Mar 2026 · 0 likes Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and…
-
Residual solvents and scavengers: what is looked for — what changed since Replied, post #19 · Analytics › Impurities & related substances · 22 Mar 2026 · 4 likes This follows post #16 rather than contradicting it. Residual solvents: traces of solvents used in purification. These are usually tested by gas chromatography, not by…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #22 · Research Methods › N-of-1 designs · 28 Feb 2026 · 2 likes Blinding: blinding yourself (not knowing which condition you are in) removes expectation bias. This is hard to do with these compounds (the appetite suppression is hard…
-
Personal import allowances, compared — a second dataset Replied, post #71 · Access › International · 18 Feb 2026 · 5 likes post #70 answers the question as asked. The question underneath it is different. Regulatory position dates: a regulatory position is only current as of when it was…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #74 · Outcomes › Progress reports · 17 Feb 2026 · 25 likes Plateaus and resets: if weight loss stalls and then resumes, that is ordinary. It is not evidence that the medication stopped working. It is not evidence that it is…
-
Coming back to: Time to steady state after a dose increase Replied, post #2 · Pharmacology › Pharmacokinetics · 15 Feb 2026 · 26 likes Fasting requirement for oral semaglutide: food and large fluid volumes reduce absorption. The fasting window (30 minutes before and 30 minutes after) is designed to…
-
Trifluoroacetate content and its consequences Replied, post #108 · Analytics › Impurities & related substances · 8 Feb 2026 · 27 likes Truncation products: fragments from incomplete synthesis or from degradation. They elute quite differently from the intact peptide because they are much smaller and…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #47 · Practice › Interactions · 6 Feb 2026 · 27 likes Picking up post #44: that is the part I would want checked first. Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug…
-
Reading a home test result without over-claiming — what changed since Replied, post #2 · Analytics › Home & field testing · 2 Feb 2026 · 29 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #72 · Pharmacology › Pharmacokinetics · 31 Jan 2026 · 1 like Worth separating two things that post #68 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Heterogeneity as information rather than as a nuisance Replied, post #75 · Evidence › Meta-analyses · 25 Jan 2026 · 0 likes Worth separating two things that post #71 runs together. When a meta-analysis is unhelpful: if the included studies are heterogeneous in population, intervention, or…
-
[2026 update] What a good consultation looks like from the other side Replied, post #11 · Clinical › Prescriber conversations · 11 Jan 2026 · 6 likes Picking up post #8: that is the part I would want checked first. How to ask for what you need: rather than "should I take this", frame it as "I understand the evidence…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #51 · Analytics › Method validation · 30 Dec 2025 · 1 like Precision and repeatability: within-run and between-run variability of the method. Acceptance criterion is typically a relative standard deviation of ≤2% for area…
-
Prescription requirements and telehealth models Replied, post #87 · Sourcing › Regulatory · 24 Dec 2025 · 0 likes Regulatory positions change: a compound's status today might differ from its status a year from now. Citing a regulatory position is worth doing only with a date…
-
Tracking that stops updating and then resumes — the long version Replied, post #49 · Sourcing › Logistics · 9 Dec 2025 · 1 like Cold packs and temperature control: inclusion of cold packs at despatch is standard. Whether they maintain temperature through transit depends on journey duration and…
-
Early satiety becoming a problem rather than a benefit Replied, post #14 · Practice › Side effects · 8 Dec 2025 · 7 likes Worth separating two things that post #10 runs together. Injection site reaction: local erythema, nodules, or induration at injection sites is reported by some people.…
-
Robustness: the parameters worth deliberately varying Replied, post #17 · Analytics › Method validation · 23 Nov 2025 · 1 like Linearity: the detector response is proportional to compound concentration across the working range. Demonstrated by running standards at multiple concentrations and…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #99 · Compounds › Tirzepatide · 18 Nov 2025 · 2 likes The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is minimal at that dose. It is a tolerance-testing dose. Confusing the purpose of a…
-
What pooling buys you and what it destroys Replied, post #62 · Evidence › Meta-analyses · 9 Nov 2025 · 0 likes Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
-
Second pass at: Programming during a large energy deficit Replied, post #30 · Nutrition & Training › Resistance training · 6 Oct 2025 · 13 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #22 · Practice › Interactions · 25 Sep 2025 · 2 likes Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes might affect the clearance or effect of warfarin if you…
-
Why catalogue breadth is not evidence of anything — what changed since Replied, post #53 · Compounds › Other compounds · 24 Sep 2025 · 25 likes When "no data" is the complete and final answer: if there is no published human data on a compound, that is the state of knowledge. Hope is not a substitute and…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #34 · Practice › Side effects · 3 Sep 2025 · 1 like Fatigue: commonly reported, frequently multifactorial. It is worth asking whether other factors have changed (sleep, training volume, diet adequacy, hydration) before…
-
When a preprint is the best available evidence and we say so Replied, post #65 · Evidence › Preprints · 17 Aug 2025 · 6 likes This follows post #62 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #107 · Compounds › Tirzepatide · 16 Aug 2025 · 6 likes Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #22 · Evidence › Journal club · 15 Aug 2025 · 0 likes Coming back to post #20, because the follow-up matters more than the original answer. Critical appraisal template: (1) What did the trial set out to estimate? (2) Could…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #69 · Sourcing › Regulatory · 4 Aug 2025 · 0 likes post #68 is right about the mechanism and I think understates the practical bit. Approval versus licensing: a compound can be approved for a specific indication in one…
-
A field-by-field walk through a certificate of analysis Replied, post #143 · Analytics › COA interpretation · 18 Jul 2025 · 20 likes Purity and content are different measurements: purity tells you what proportion of the detected material is the intended species. Content tells you how much of the…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #46 · Data & Tools › Calculators · 8 Jul 2025 · 0 likes Reporting bugs: if you notice a calculator giving wrong results, report it in this subcategory. Bugs are fixed when identified.
-
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #58 · Evidence › Journal club · 25 Jun 2025 · 0 likes post #57 answers the question as asked. The question underneath it is different. SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #49 · Compounds › Repair & healing peptides · 24 Jun 2025 · 22 likes I read post #47 twice before replying, because I had assumed the opposite. Publication patterns in the BPC-157 literature: a large proportion of the evidence comes from…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #39 · Compounds › Oral incretins · 29 May 2025 · 22 likes Dose numbers for oral formulations are not comparable to injectable ones. The 14 mg oral dose is not equivalent to any injectable dose in the traditional comparison…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #95 · Compounds › Tirzepatide · 27 May 2025 · 27 likes Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that means steady state is reached slightly faster and the post-dose…
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #39 · Evidence › Journal club · 14 May 2025 · 19 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Follow-up: Documentation that appears only after payment Replied, post #56 · Sourcing › Red flags · 8 May 2025 · 5 likes Evasion when asked: if a supplier does not clarify when asked specifically for method details, counter-ion form, or batch origin, that itself is a red flag worth…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #102 · Compounds › Semaglutide · 3 May 2025 · 0 likes Picking up post #99: that is the part I would want checked first. Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the…
-
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #47 · Compounds › Secretagogues & GH axis · 21 Apr 2025 · 17 likes Reading a rodent study on a secretagogue without over-extrapolating: rodent studies can show a mechanism is plausible. They cannot show magnitude of effect in humans or…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #49 · Practice › Interactions · 15 Apr 2025 · 12 likes Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #12 · Data & Tools › Calculators · 11 Apr 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Adducts: sodium, potassium, and the peak you did not expect Replied, post #50 · Analytics › Mass spectrometry · 30 Mar 2025 · 14 likes Picking up post #47: that is the part I would want checked first. Mass accuracy is expressed in parts per million. It is the difference between observed and theoretical…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #122 · Access › International · 25 Mar 2025 · 15 likes Compounding in different countries: some countries allow pharmacy compounding under defined conditions; others do not. The rules are jurisdiction-specific and change.
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #112 · Analytics › COA interpretation · 22 Mar 2025 · 0 likes Worth separating two things that post #108 runs together. Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the…
-
Maintainer handover: how it works Replied, post #59 · Meta › Wiki maintenance · 17 Mar 2025 · 1 like Evidence synthesis: if you think a page should cover recent evidence or a new development, suggesting specific content helps the maintainer prioritise updates.
-
Validating a method you did not develop — does this still hold? Replied, post #107 · Analytics › Method validation · 13 Mar 2025 · 30 likes Range: the concentration range over which the method has been validated. Going outside the validated range is going outside the method's demonstrated performance.
-
Follow-up: What other technical communities get right that we do not Replied, post #33 · Lounge › Off topic · 7 Mar 2025 · 0 likes post #32 is right about the mechanism and I think understates the practical bit. Lower-stakes conversation that does not belong in the technical categories. Still…
-
Consistent declarations and why they matter more than clever ones Replied, post #78 · Sourcing › Logistics · 24 Feb 2025 · 1 like Coming back to post #76, because the follow-up matters more than the original answer. Reshipment after seizure: if a parcel is seized, some suppliers will reship;…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #56 · Compounds › Cagrilintide & amylin analogues · 26 Jan 2025 · 0 likes Reading the phase 2 paper: it establishes tolerability and efficacy in a selected population on a defined dose escalation. It does not establish the lowest effective…
-
When to suspect the method rather than the sample Replied, post #62 · Analytics › Method validation · 7 Jan 2025 · 0 likes Robustness: the method gives consistent results when minor parameters vary. Tested by deliberately varying pH, temperature, flow rate, and mobile phase composition…
-
Why our vendor pages link the storefront and mark it sponsored Replied, post #19 · Sourcing › Vendor reports · 5 Jan 2025 · 6 likes Lot matching: confirm the lot number on the certificate matches the lot number on the vial. A result from a different lot is not evidence about your vial.
-
Identical chromatograms across two different lots Replied, post #71 · Sourcing › Red flags · 3 Jan 2025 · 0 likes This follows post #68 rather than contradicting it. Inconsistency across documents: a certificate stating one purity, a website claiming another, and a supplier's…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #72 · Compounds › Semaglutide · 23 Dec 2024 · 10 likes The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #152 · Analytics › COA interpretation · 15 Dec 2024 · 27 likes A certificate of analysis is a statement by its issuer that a defined test was performed on a defined lot and produced a defined result. That is all it is, and it is…
-
The topic list is dense — is that deliberate? Replied, post #65 · Meta › Site feedback · 11 Dec 2024 · 2 likes Moderation decisions: if you disagree with a moderation decision, raising it here gives it visibility. Staff will reconsider if you make a substantive case.
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #55 · Evidence › Journal club · 9 Dec 2024 · 3 likes post #54 is right about the mechanism and I think understates the practical bit. PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not…
-
Coming back to: Reading a meta-analysis you disagree with, fairly Replied, post #4 · Evidence › Meta-analyses · 8 Dec 2024 · 5 likes Subgroup analysis: sometimes a meta-analysis reports separate pooled estimates for different subgroups (e.g., by baseline body mass index or by trial duration). Be…
-
Why "any advice?" is the least effective ending for a post Replied, post #105 · Start Here › How to Ask · 4 Dec 2024 · 1 like Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room temperature?" is more productive than no question at all. People…
-
A revision dispute resolved on the topic rather than in the history — a second dataset Replied, post #17 · Meta › Wiki maintenance · 25 Oct 2024 · 12 likes Coming back to post #15, because the follow-up matters more than the original answer. Evidence synthesis: if you think a page should cover recent evidence or a new…
-
Guidelines revision: what changed and why Replied, post #41 · Meta › Announcements · 26 Jul 2024 · 20 likes Questions welcomed: if an announcement is unclear, asking for clarification is welcome. Staff will explain their reasoning.